Drug Type Small molecule drug |
Synonyms Mexidol, 3-HP |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H12ClNO |
InChIKeyKZUIXWYHQJZUOK-UHFFFAOYSA-N |
CAS Registry13258-59-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Infarction | Phase 3 | Russia | 05 Nov 2019 | |
Brain Infarction | Phase 3 | Uzbekistan | 05 Nov 2019 | |
Anxiety Disorders | Phase 3 | Russia | 13 Jul 2019 | |
Ischemic stroke | Phase 3 | Russia | 06 Mar 2015 | |
Cognition Disorders | Phase 3 | - | - | |
Myocardial Ischemia | Clinical | - | - | |
Pancreatitis | Clinical | - | - | |
Peptic Ulcer | Clinical | - | - | |
ischemic brain injury | Preclinical | - | - | 01 Feb 2020 |
Phase 3 | 150 | (Mexidol®) | byyfalqjnv(elbwdxglrw) = cumvrpmjbs udfcjmhtys (vamkasbqxt, 0.768) View more | - | 24 Feb 2025 | ||
Placebo (Placebo) | byyfalqjnv(elbwdxglrw) = wiuoelyenm udfcjmhtys (vamkasbqxt, 0.947) View more |